Heart Transplantation as a Treatment Method for Refractory Heart Failure due to Post-myocarditis Dilated Cardiomyopathy: a Clinical Case

Background. Implementation of mechanical circulatory support and heart transplantation technologies in paediatric clinical practice is changing approaches of diagnostics and treatment of heart failure (HF) in children. The experience of carrying out such operations in Russian Federation is extremely limited until recently due to absence of legal mechanisms of people declaration of intention recording about postmortal use of organs for transplantation.

Clinical Case Description. The rare clinical case of drug-refractory (cardiotonic agents and cardioverter defibrillator implantation) chronic cardiac failure caused by post-myocarditis dilated cardiomyopathy (DCM) which demanded heart transplantation. Postoperative course, specific and non-specific complications, diagnostics and correction approaches are described.

Conclusion. In the absence of proper analysis of non-specific slight symptoms myocarditis can progress to DCM and be complicated by development of refractory HF. The only method of sustaining child’s life in such case is heart transplantation which is connected with high risk of numerous and life-threatening complications.

1. Klinicheskie rekomendatsii «Khronicheskaya serdechnaya nedostatochnost’ u detej»(utv. Minzdravom Rossii) [Internet]. Ed by Baranov AA, NamazovaBaranova LS, Basargina EN, i dr. Moscow: Soyuz pediatrov Rossii; Assotsiatsiya detskikh kardiologov Rossii; 2016. 16 p. (In Russ).] Доступно по: http://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=326053&fld=134&dst=100001,0&rnd=0.24511092809802348#03927419651004245. Ссылка активна на 12.01.2019.

2. Das BB. Current state of pediatric heart failure. Children (Basel). 2018;5(7). pii: E88. doi: 10.3390/children5070088.

3. Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United Sates. A policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3): 606–619. doi: 10.1161/HHF.0b013e318291329a.

4. Rossano JW, Kim JJ, Decker JA, et al. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012;18(6):459–470. doi: 10.1016/j.cardfail.2012.03.001.

5. Nandi D, Lin KY, O’Connor MJ, et al. Hospital charges for pediatric heart failure related hospitalizations admissions in the United States from 2000 to 2009. Pediatr Cardiol. 2016;37(3):512–518. doi: 10.1007/s00246-015-1308-0.

6. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. doi: 10.1002/ejhf.592.

7. Masarone D, Valente F, Rubino M, et al. Pediatric heart failure: a practical guide to diagnosis and management. Pediatr Neonatol. 2017;58(4):303–312. doi: 10.1016/j.pedneo.2017.01.001.

8. Hinton RB, Ware SM. Heart failure in pediatric patients with congenital heart disease. Circ Res. 2017;120(6):978–994. doi: 10.1161/CIRCRESAHA.116.308996.

9. Rhee EK, Canter CE, Basile S, et al. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome? J Heart Lung Transplant. 2007;26(5):447–452. doi: 10.1016/j.healun.2007.02.005.

10. Schweiger M, Stiasny B, Dave H, et al. Cardiac transplantation in a neonate — first case in Switzerland and European overview. Clin Transplant. 2017;31 Issue 5: e12935. doi: 10.1111/ctr.12935.

11. Goldfarb SB, Levvey BJ, Edwards LB, et al. The registry of the international society for heart and lung transplantation: nineteenth pediatric lung and heart-lung transplantation report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35(10):1196–1205. doi: 10.1016/j.healun.2016.08.019.

12. Pfitzer C, Helm PC, Ferentzi H, et al. Changing prevalence of severe congenital heart disease: results from the national register for congenital heart defects in Germany. Congenit Heart Dis. 2017;12(6):787–793. doi: 10.1111/chd.12515.

13. Kirklin JK. Current challenges in pediatric heart transplantation for congenital heart disease. Curr Opin Organ Transplant. 2015; 20(5):577–583. doi: 10.1097/MOT.0000000000000238.

14. Dipchand AI. Current state of pediatric cardiac transplantation. Ann Cardiothorac Surg. 2018;7(1):31–55. doi: 10.21037/acs.2018.01.07.

15. Caviedes Bottner P, Cordova Fernandez T, Larrain Valenzuela M, et al. [Dilated cardiomyopathy and severe heart failure. An update for pediatricians. (In English, Spanish).] Arch Argent Pediatr. 2018;116(3):e421–e428. doi: 10.5546/aap.2018.eng.e421.

16. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2013;34(33):2636–2648, 2648a–2648d. doi: 10.1093/eurheartj/eht210.

17. Almond CS, Hoen H, Rossano JW, et аl.; Pediatric Heart Transplant Study (PHTS) Group Registry. Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. J Heart Lung Transplant. 2018;37(4):441–450. doi: 10.1016/j.healun.2017.03.013.

18. Becker P, Besa S, Riveros S, et al. [Results of a national program of pediatric heart transplantation: strengths and weakness. (In Spanish).] Rev Chil Pediatr. 2017;88(3):367–376. doi: 10.4067/S0370-41062017000300009.

19. Raissadati A, Pihkala J, Jahnukainen T, et al. Late outcome after pediatric heart transplantation in Finland. Interact Cardiovasc Thorac Surg. 2016;23(1):18–25. doi: 10.1093/icvts/ivw086.

20. Dipchand AI, Edwards LB, Kucheryavaya AY, et al. The registry of the International society for heart and lung transplantation: seventeenth official pediatric heart transplantation report-2014; focus theme: retransplantation.J Heart Lung Transplant. 2014; 33(10):985–995. doi: 10.1016/j.healun.2014.08.002.

21. Rostad CA, Wehrheim K, Kirklin JK, et al. Bacterial infections after pediatric heart transplantation: epidemiology, risk factors and outcomes. J Heart Lung Transplant. 2017;36(9):996–1003. doi: 10.1016/j.healun.2017.05.009.

22. Mahle WT, Fourshee MT, Naftel DM, et al. Does cytomegalovirus serology impact outcome after pediatric heart transplantation? J Heart Lung Transplant. 2009;28(12):1299–1305. doi: 10.1016/j.healun.2009.07.011.

23. Transplantatsiya serdtsa. Natsional’nye klinicheskie rekomendatsii (utv. resheniem Koordinatsionnogo soveta obshcherossijskoj obshchestvennoj organizatsii transplantologov «Rossijskoe trans plantologicheskoe obshchestvo» 29 noyabrya 2013 g. Ed by Got’e SV, Khomyakov SM, Arzumanov SV, i dr. Rossijskoe transplantologicheskoe obshchestvo; 2013. (In Russ). Доступно по: https://freedocs.xyz/pdf-483241234. Ссылка активна на 12.01.2019.

24. Zablah JE, Everitt MD, Wilson N. Accelerated cardiac allograft vasculopathy after pediatric heart transplantation. Am J Transplantat. 2017;17:2983–2985. doi: 10.1111/ajt.14475.

25. Miriuka SG, Langman LJ, Evrovski J, et al. Thromboembolism in heart transplantation: role of prothrombin G20210A and factor V Leiden. Transplantation. 2005;80(5):590–594. doi: 10.1097/01.tp.0000170545.42790.6f.

26. Clemmensen TS, Holm NR, Eiskjær H, et al. ST elevation infarction after heart transplantation induced by coronary spasms and mural thrombus detected by optical coherence tomography. Case Rep Transplant. 2016;2016:1863869. doi: 10.1155/2016/1863869.

27. Kobayashi D1, Du W, L’ecuyer TJ. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients. Pediatr Transplant. 2013;17(5):436–440. doi: 10.1111/petr.12095.

28. Mahle WT, Vincent RN, Berg AM, Kanter KR. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. J Heart Lung Transplant. 2005; 24(1):63–66. doi: 10.1016/j.healun.2003.10.013.

29. Greenway SC, Butts R, Naftel DC, et al. Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents. J Heart Lung Transplant. 2016;35(4): 457–465. doi: 10.1016/j.healun.2015.10.040.

30. Fenton M, Mahmood A, Burch M, et al. Comparative study of pediatric coronary allograft vasculopathy between single centers in North America and United Kingdom. Transplant Proc. 2018;50(10): 3705–3709. doi: 10.1016/j.transproceed.2018.06.022.

31. Castleberry C, Pruitt E, Ameduri R, et al. Risk stratification to determine the impact of induction therapy on survival, rejection and adverse events after pediatric heart transplant: A multiinstitutional study. J Heart Lung Transplant. 2018;37(4):458–466. doi: 10.1016/j.healun.2017.05.010.

32. Carlo WF, Bryant R, Zafar F. Comparison of 10-year graft failure rates after induction with basiliximab or anti-thymocyte globulin in pediatric heart transplant recipients — the influence of race. Pediatr Transplant. 2019;8:e13366. doi: 10.1111/petr.13366.

33. Rossano JW, Jefferies JL, Pahl E, et al. Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group. J Heart Lung Transplant. 2017;36(4):427–433. doi: 10.1016/j.healun.2016.09.009.

34. Morgan CT, Manlhiot C, McCrindle BW, et al. outcome, incidence and risk factors for stroke after pediatric heart transplantation: an analysis of the international society for heart and lung transplantation registry. J Heart Lung Transplant. 2016;35(5): 597–602. doi: 10.1016/j.healun.2016.01.1226.

35. Vanderlaan RD, Manlhiot C, Edwards LB, et al. Risk factors for specific causes of death following pediatric heart transplant: an analysis of the registry of the International Society of Heart and Lung Transplantation. Pediatr Transplant. 2015 Dec;19(8):896–905. doi: 10.1111/petr.12594.

36. Sehgal S, Shea E, Kelm L, Kamat D. Heart transplant in children: what a primary care provider needs to know. Pediatr Ann. 2018;47(4):e172–e178. doi: 10.3928/19382359-20180319-01.